These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 3044040)

  • 1. Evaluation of lopamidol and diatrizoate in excretory urography: a double-blind clinical study.
    Cochran ST; Ballard JW; Katzberg RW; Barbaric ZL; Spataro R; Iwamoto K; Lee JJ
    AJR Am J Roentgenol; 1988 Sep; 151(3):523-7. PubMed ID: 3044040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-blind comparison of iodamide and diatrizoate for excretory urography.
    Rosenfield AT; Putman CE; Ulreich S; Koss N
    Yale J Biol Med; 1977; 50(6):631-6. PubMed ID: 345632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iohexol for excretory urography: a comparative study.
    Winfield AC; Dray RJ; Kirchner FK; Muhletaler CA; Price RR
    AJR Am J Roentgenol; 1983 Sep; 141(3):571-3. PubMed ID: 6349311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iopamidol: new, nonionic contrast agent for excretory urography.
    Thompson WM; Foster WL; Halvorsen RA; Dunnick NR; Rommel AJ; Bates M
    AJR Am J Roentgenol; 1984 Feb; 142(2):329-32. PubMed ID: 6607602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iohexol vs. diatrizoate. A comparative study in intravenous urography.
    Rankin RN; Eng FW
    Invest Radiol; 1985; 20(1 Suppl):S112-4. PubMed ID: 3972525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind study comparing the efficiency, tolerance and renal effects of iopromide and iopamidol.
    Kennedy C; Rickards D; Lee S; Sharp MB; Dawson P
    Br J Radiol; 1988 Apr; 61(724):288-93. PubMed ID: 3285943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iopamidol arteriography: discomfort and pain.
    Dotter CT; Rösch J; Erlandson M; Buschman RW; Ogilvie R
    Radiology; 1985 Jun; 155(3):819-21. PubMed ID: 3890014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Excretory urography: comparison of the ionic contrast medium amidotrezoic acid with the non-ionic contrast medium iohexol].
    Grabenwöger F; Dock W; Pinterits F; Metz V
    Wien Med Wochenschr; 1989 Feb; 139(3):48-50. PubMed ID: 2650470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ioversol in intravenous excretory urography. Evaluation of radiographic quality, patient tolerance and safety in four clinical studies.
    Jahn H; Müller-Späth R
    Ann Radiol (Paris); 1992; 35(4 Pt 2):297-302. PubMed ID: 1296496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of iopamidol and diatrizoate in excretory urography: a double-blind clinical study.
    Beam C; Dunnick NR
    Invest Radiol; 1990 Nov; 25(11):1255-7. PubMed ID: 2254061
    [No Abstract]   [Full Text] [Related]  

  • 11. [A study of iopamidol (Iopamiron 370) in intravenous urography in the patients with previous adverse reactions to contrast media and history of allergy].
    Kondo K; Kamidono S; Hamami G
    Hinyokika Kiyo; 1988 Oct; 34(10):1845-51. PubMed ID: 3245531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Quality control in urography with iopamidol and iohexol. A parallel comparison].
    Stacul F; Bazzocchi M; Zanella F; Abbona M; Ukovich W
    Radiol Med; 1987 Mar; 73(3):196-8. PubMed ID: 3562919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective randomised controlled trial to determine the early and late reactions after the use of iopamidol 340 (Niopam) and iomeprol 350 (Iomeron) in cardiac catheterisation.
    Vijayalakshmi K; Kunadian B; Wright RA; Hall JA; Stewart MJ; Davies A; Sutton A; de Belder MA
    Eur J Radiol; 2007 Feb; 61(2):342-50. PubMed ID: 17101256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unequal doses of ioversol versus diatrizoate for urography.
    Baker MK; Kopecky KK; Bogan M; Wass JL
    Urol Radiol; 1990; 12(3):168-72. PubMed ID: 2281582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose clinical urography with the low-osmolality contrast agent Hexabrix: comparison with a conventional contrast agent.
    Spataro RF; Katzberg RW; Fischer HW; McMannis MJ
    Radiology; 1987 Jan; 162(1 Pt 1):9-14. PubMed ID: 3538156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nephrotoxicity of nonionic low-osmolality versus ionic high-osmolality contrast media: a prospective double-blind randomized comparison in human beings.
    Katholi RE; Taylor GJ; Woods WT; Womack KA; Katholi CR; McCann WP; Moses HW; Dove JT; Mikell FL; Woodruff RC
    Radiology; 1993 Jan; 186(1):183-7. PubMed ID: 8416561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Late reactions to a radiologic contrast media (Iopamidol-Bracco). Prospective study].
    Bartolucci F; Cecarini M; Gabrielli G; Abbiati R; Barberio M; Busilacchi P
    Radiol Med; 2000 Oct; 100(4):273-8. PubMed ID: 11155455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of intravenous drip infusion excretory urography using ionic and non-ionic contrast media].
    Onitsuka H; Araki A; Torii Y; Tsukuda M; Murakami J; Ino A; Hashiguchi N; Masuda K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1989 Jul; 49(7):915-20. PubMed ID: 2798075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, double-blind, parallel group trial of iomeprol, iohexol and iopamidol in intravenous urography.
    Harding JR; Bertazzoli M; Spinazzi A
    Br J Radiol; 1995 Jul; 68(811):712-5. PubMed ID: 7640924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of the side effects of urographic contrast media (iothalamate, diatrizoate, iodamide, iopamidol) within the scope of a CT study].
    Stellamor K; Hruby W; Assinger S; Luckner H
    Radiologe; 1984 Oct; 24(10):488-90. PubMed ID: 6505221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.